Home › Funds › Balyasny Asset Management › MANE
Balyasny Asset Management position in MANE
VERADERMICS INC · Health Care
Latest position (Q2 2026)168.93K sh
Reported value held$20.77M
Portfolio Weight0.03%
First reportedQ1 2026
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 532.91K | $33.65M | New |
| Q2 2026 | 168.93K | $20.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MANE
- Fidelity Management & Research (FMR) 3.20M sh · $394.02M · Q2 2026
- Citadel Advisors 1.88M sh · $230.85M · Q2 2026
- BlackRock Inc 1.59M sh · $195.94M · Q2 2026
- Viking Global Investors 1.56M sh · $191.97M · Q2 2026
- JPMorgan Chase & Co 1.17M sh · $144.24M · Q2 2026
- D. E. Shaw & Co 1.01M sh · $124.62M · Q2 2026
- Maverick Capital 789.98K sh · $97.12M · Q2 2026
- UBS Group AG 670.73K sh · $82.46M · Q2 2026
- Marshall Wace 585.56K sh · $71.99M · Q2 2026
- Geode Capital Management 508.07K sh · $62.48M · Q2 2026
- BNY Mellon 346.58K sh · $42.61M · Q2 2026
- Baron Funds 229.58K sh · $28.22M · Q2 2026